FOXTALESerums

0.15% Retinol Night Serum

An encapsulated retinol night serum at a brand-confirmed 0.15% in an emulsion base. The encapsulation system uses Poloxamer 235, a block copolymer that protects retinol from premature degradation and enables slower, more controlled release into the skin - reducing the irritation typically associated with free retinol. EGCG (Epigallocatechin Gallate) from green tea provides anti-inflammatory support. Niacinamide at position 19 adds a synergistic anti-ageing mechanism. Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus, position 21) - a UV filter - appears in this night product specifically to photostabilise the retinol in the packaging, not as a skin UV filter. BHT and BHA (Butylated Hydroxytoluene and Butylated Hydroxyanisole) are antioxidant stabilisers at trace positions.

0.15% Retinol Night Serum
MOSTLYCLEAN
Mostly Clean
Best for
  • Skincare beginners
  • Daily Use (Night)
Avoid if
  • Using other actives or daytime without SPF
  • Pregnant or trying to conceive

₹599 · ₹20/ml • Analysed 11 June 2026

India Context

Retinol at 0.15% via an encapsulated delivery system is appropriate for first-time retinol users, and particularly relevant for Indian skin: darker skin tones (Fitzpatrick IV-VI) carry higher PIH risk from retinol-induced irritation, so a controlled-release, lower-concentration entry point reduces this risk significantly. Apply at night only. Mandatory SPF 30+ the next morning. India's heat accelerates retinol degradation in open packaging - close immediately after use.

This is a web evidence review, not a Clean Sheet certification. We checked the ingredient list, publicly available test reports, marketing claims, and formula logic using only public information available at the time of review.

At a glance

Alcohol free
Paraben free

What was checked

Strong
0.15% Retinol (Encapsulated)Verified

Brand-confirmed; Poloxamer 235 encapsulation system disclosed.

Published evidence
2x faster than regular retinolNeeds context

Based on encapsulation supplier data, not an independent published trial for this formula.

Brand claim
Not suitable during pregnancyVerified

Pregnancy contraindication is communicated on packaging - correct and necessary.

Published evidence
Verified: confirmed from public evidenceSupported: consistent with available evidenceNeeds context: relevant for some usersNot verified: could not be confirmed

The breakdown

Mostly credible with gaps

Public Evidence Score across 5 pillars. Open any row for the full rationale.

Ingredient Safety
Strong

Retinol at 0.15% is below the EU guideline limit of 0.3% for face leave-on products.

Retinol at 0.15% is below the EU guideline limit of 0.3% for face leave-on products. All retinoids carry a mandatory pregnancy contraindication. BHT and BHA at near-final positions are antioxidant stabilisers within permitted limits - these are not preservatives. Allergen Free Fragrance (synthetic, not fragrance-free) is present. Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus) is used here as an in-bottle retinol photostabiliser, not as a skin-applied UV filter. Cyclopentasiloxane and Dimethicone in the emulsion base have a good skin safety profile.

Formula Logic
Strong

Encapsulated retinol via Poloxamer 235 is a meaningful delivery advance: the copolymer shell protects retinol from oxidation in storage and releases it progressively on skin...

Encapsulated retinol via Poloxamer 235 is a meaningful delivery advance: the copolymer shell protects retinol from oxidation in storage and releases it progressively on skin contact, achieving comparable efficacy to free retinol with significantly reduced irritation. EGCG from green tea at position 13 has anti-inflammatory clinical evidence relevant to the retinisation adjustment period. Niacinamide at position 19 adds independent collagen-supporting and brightening mechanisms. The emulsion base is appropriate for a retinol delivery vehicle.

Claims Evidence
Strong

Good evidence for stated claims based on public information.

Retinol at 0.15% is brand-confirmed. The Poloxamer 235 encapsulation system is disclosed on the product page - above-average transparency for an Indian brand. The '2x faster than regular retinol' claim for encapsulated delivery is based on supplier-commissioned studies, not independent peer-reviewed trials. Pregnancy contraindication is communicated on packaging.

Test Transparency
Grade CFair

No independent clinical study has been published for this formula.

No independent clinical study has been published for this formula. The '2x faster than regular retinol' claim references encapsulation technology supplier data, not an independent trial for this specific product. Retinol 0.15% is brand-confirmed. Encapsulation mechanism is disclosed.

Consumer Clarity
Strong

Retinol at 0.15% is clearly stated.

Retinol at 0.15% is clearly stated. Pregnancy contraindication is communicated. The Poloxamer 235 encapsulation is explained. Uvinul A Plus's role as an in-bottle stabiliser (not a skin SPF) is not explained to consumers - potentially confusing given its presence in a night product.

Ingredient list

Strong
SafeNoteCaution
Ingredient
Aqua
Propylene Glycol
Dicaprylyl Carbonate
Dimethicone
Caprylic/Capric Triglyceride
Cetearyl Olivate
Sorbitan Olivate
Glyceryl Monostearate
Propanediol
Behenyl Alcohol
Retinol
Poloxamer 235
Epigallocatechin Gallate
Polysorbate 20
BHT
BHA
Sodium Ascorbate
Betaine
Niacinamide
Garcinia Indica Seed Butter
Diethylamino Hydroxybenzoyl Hexyl Benzoate
Polymethylsilsesquioxane
Phenoxyethanol
Tocopherol
Allantoin
Palmitoyl Glycine
Sodium Hyaluronate
Ethylhexylglycerin
Octenidine HCl
Ammonium Acryloyldimethyltaurate/VP Copolymer
Disodium EDTA
Sodium Hydroxide
Allergen Free Fragrance

INCI order as declared on packaging. Position reflects approximate concentration (high to low).

Regulatory screen

Clear
EU 1223/2009EU Cosmetics Regulation - Annexes II–VI

No banned substances; Allergen Free Fragrance formulated to exclude 26 EU-listed allergens per Regulation 2023/1545

India CR 2020India Cosmetics Rules, CDSCO

No flagged substances

Health Canada HotlistCanada prohibited & restricted ingredients

No flagged substances

US FDA 21 CFRUS FDA Parts 700–740

No flagged substances

MFDS KoreaKorea Cosmetics Act

No flagged substances

ECHA SVHCSubstances of Very High Concern

No flagged substances

IARCCarcinogen classifications Groups 1/2A/2B

No flagged substances

AICIS AustraliaAustralian industrial chemical safety

No flagged substances

TGA AustraliaTherapeutic claims (if applicable)

No flagged substances

Canada NHPIDNatural health product ingredients

No flagged substances

Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.

Claims checked

Strong
0.15% Retinol (Encapsulated)Publicly supported

Brand-confirmed; Poloxamer 235 encapsulation system disclosed.

Evidence visible

2x faster than regular retinolNeeds proof

Based on encapsulation supplier data, not an independent published trial for this formula.

Mentioned only

Not suitable during pregnancyPublicly supported

Pregnancy contraindication is communicated on packaging - correct and necessary.

Evidence visible

What would strengthen this review

Public evidence the brand could provide to close verification gaps

  • Independent clinical trial for encapsulated retinol efficacy at 0.15% not published
  • Uvinul A Plus role as in-bottle stabiliser not explained to consumers
  • BHT and BHA described as stabilisers - distinction from preservatives not communicated
About this review

A thoughtfully designed beginner retinol serum. The encapsulated delivery via Poloxamer 235 is a genuine formulation advantage for Indian skin, where retinol-associated PIH from irritation is a real risk for darker Fitzpatrick types. Pregnancy contraindication and nighttime-only use guidance are clearly communicated.

Are you the brand? If you have published test data or want to request a re-review, write to us at hello@thecleansheet.in.

Independent reviewPublic evidence only
Full methodology
  • What global regulations say about each ingredient
  • What toxicology evidence shows at cosmetic concentrations
  • What formula concentration context changes
  • What the product format and leave-on contact time changes
  • What the stated user group needs
  • What published test evidence confirms
  • What the brand is claiming vs what evidence supports

More from Foxtale

See all
Back to Foxtale
WhatsApp Community

Join The Clean Sheet™ community

Science-backed beauty tips, ingredient alerts, and early access. Straight to your WhatsApp.

Join for free →